drugset / Trial / NCT03780049

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

NCT03780049

Phase 3 Unknown 304 enrolled Sun Yat-sen University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Hepatic artery infusion chemotherapy (HAIC) is effective and safe for hepatocellular carcinoma (HCC). Recombinant Human Type-5 Adenovirus (H101) is safe for HCC. The purpose of this study is to evaluate the efficacy and safety of HAIC combined with H101 compared with HAIC alone in patients with unresectable hepatocellular carcinoma (HCC) at barcelona clinic liver cancer A-B stage.

Timeline

Start
2018-10-01
Primary completion
2023-10-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject H101 Other / unclassified 0.5 ml Other